PMAQX
Price
$46.81
Change
-$0.32 (-0.68%)
Updated
Oct 7 closing price
Net Assets
33.08B
TMITX
Price
$11.26
Change
-$0.06 (-0.53%)
Updated
Oct 7 closing price
Net Assets
147.3M
Interact to see
Advertisement

PMAQX vs TMITX

Header iconPMAQX vs TMITX Comparison
Open Charts PMAQX vs TMITXBanner chart's image
Principal MidCap R6
Price$46.81
Change-$0.32 (-0.68%)
VolumeN/A
Net Assets33.08B
Transamerica Mid Cap Growth I3
Price$11.26
Change-$0.06 (-0.53%)
VolumeN/A
Net Assets147.3M
PMAQX vs TMITX Comparison Chart in %
View a ticker or compare two or three
VS
PMAQX vs. TMITX commentary
Oct 09, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PMAQX is a Hold and TMITX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
PMAQX has more cash in the bank: 33.1B vs. TMITX (147M). PMAQX pays higher dividends than TMITX: PMAQX (0.19) vs TMITX (0.00). PMAQX was incepted earlier than TMITX: PMAQX (9 years) vs TMITX (12 years). TMITX (0.79) is less costly to investors than PMAQX (0.59). TMITX is a more actively managed with annual turnover of: 106.00 vs. PMAQX (10.50). PMAQX (0) and TMITX (0) have matching initial minimum investment requirements. TMITX annual gain was more profitable for investors over the last year : 11.31 vs. PMAQX (4.57). PMAQX return over 5 years is better than : 42.57 vs. TMITX (-11.70).
PMAQXTMITXPMAQX / TMITX
Total Expense Ratio0.590.7975%
Annual Report Gross Expense Ratio0.590.7975%
Fund Existence9 years12 years-
Gain YTD5.60211.52749%
Front LoadN/AN/A-
Min. Initial Investment00-
Min. Initial Investment IRAN/AN/A-
Net Assets33.1B147M22,517%
Annual Yield % from dividends0.190.00-
Returns for 1 year4.5711.3140%
Returns for 3 years56.1967.7083%
Returns for 5 years42.57-11.70-364%
Returns for 10 yearsN/A-1.34-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
RYLSX91.79N/A
N/A
Rydex Leisure A
RLCAX9.33N/A
N/A
Columbia Disciplined Value A
HLMGX37.80N/A
N/A
Harding Loevner Global Equity Advisor
SHSKX67.99N/A
N/A
BlackRock Health Sciences Opps K
OBSIX28.95N/A
N/A
Oberweis Small-Cap Opportunities Instl